GlassScriptPhysician profile
Daniel Thomas Childes
NPI 1073290110
$7,611.81
in general payments reported to CMS, 2019-2025
25 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,517 · 2024: $4,167 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,965 · Travel and Lodging: $1,325 · Education: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,965.47 |
| Travel and Lodging | $1,324.84 |
| Education | $321.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,544.08 | 2023-2025 | Na, Motoband, Tfn-Advance |
| Medical Device Business Services, INC. | $2,367.46 | 2023-2024 | Actis, Vistaseal |
| Stryker Corporation | $538.57 | 2023-2025 | Alphavent, Na, Vitoss |
| Kerecis Limited | $180.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kuros Biosciences USA, INC | $163.52 | 2023 | |
| Solventum Corporation | $161.70 | 2024-2025 | Prevena, 3m Cavilon, Activ.A.C. |
| Intrinsic Therapeutics | $160.50 | 2024 | Barricaid Acd (Annular Closure Device) |
| Axogen | $139.81 | 2023 | Avance Nerve Graft |
| Bioventus LLC | $137.82 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Bone Support INC. | $135.90 | 2024 | Ceramentbone Void Filler, Cerament G |
| Next Science LLC | $133.09 | 2024 | Xperience, Blastx, Surgx |
| My01 INC. | $125.40 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Lifenet Health | $123.64 | 2024 | Allograft Vmis Delivery System |
| Vertex Pharmaceuticals Incorporated | $119.94 | 2025 | |
| Biocomposites INC | $119.85 | 2025 | Stimulan |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bonalive INC | $113.51 | 2024 | |
| Kci USA, INC. | $99.99 | 2023 | Activ.A.C., V.A.C. Veraflo, Prevena Restor Axioform |
| Moximed, INC | $73.46 | 2025 | Misha Knee System, Small, Left |
| Organogenesis INC. | $44.31 | 2024 | Puraply Franchise |
| Team 1, LLC | $36.25 | 2025 | |
| Arteriocyte Medical Systems, INC. | $24.35 | 2025 | Magellan |
| Convatec INC. | $19.52 | 2025 | |
| Ethicon US, LLC | $17.73 | 2025 | Dermabond Prineo, Stratafix |
| Teleflex LLC | $17.36 | 2025 | Quikclot |
| Avanos Medical | $13.08 | 2023 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Childes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.